At F1000, we are today announcing a new fully Open Access publishing program across biology and medicine, F1000 Research, which will launch later this year. It is intended to address the major issues afflicting scientific publishing today: timely dissemination of research, peer review, and sharing of data.
We are delighted to announce our plans to launch F1000 Research (from Faculty of 1000), a novel, fully Open Access publishing program. The project, which will begin publishing later this year, is intended to address three major issues afflicting scientific publishing today: timely dissemination of research, peer review and sharing of data. F1000 Research will…
Many are quick to criticize the peer review process, but are there any viable alternatives?
F1000 founder and chairman Vitek Tracz addresses a former Faculty Member’s critique of our subscription service.
With a tobacco giant using freedom of information laws to access smoking study data, we ask the question – how much of scientific research should be accessible?
F1000 chairman, Vitek Tracz, announces a new model for data publishing, with open peer review.
Morgan, in her latest post here at Naturally Selected, makes the point that indirect action is more effective than confrontation at getting your ideas accepted. The thought occurred to me that the real staring-eyed prophets–you know the ones I mean, we’ve all had those emails–probably wouldn’t be convinced by such an argument, and as they’re…
Bell Labs was a remarkable enterprise which, according to Wikipedia, contributed to the development of cell phones, wlan (wifi), semiconductors, compression algorithms, and many more developments that changed the way people interact with technology. Bell Labs worked well because they brought together innovative thinkers, and let them innovate. People there didn’t have to write grant…
Following David Drubins editorial in MBoC I gathered some likely looking characters to have a chat about the current state of review. Hear what they had to say.
In case you haven’t seen it already, there’s an intriguing new article in Infection and Immunity, Retracted Science and the Retraction Index. It’s by the Editor in Chief of Infect. Immun. Ferric C. Fang and Arturo Casadevall–Editor in Chief of mBio and long-serving F1000 Member in Medical Microbiology. Fang, with Casadevall, looked at retractions in…
